Return on investment (ROI), also called return on invested capital, is the profit a company earns for every dollar of long-term capital from both lenders and shareholders, shown as a percentage. It is net income divided by long-term debt plus shareholder equity, and the table shows both amounts. Because debt is included in the base, ROI does not rise just because a company replaces equity with borrowing, which sets it apart from ROE. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.
AMGEN INC roi for the quarter ending 2026-06-30 was 11.75%, a 17.25% increase year-over-year.
AMGEN INC roi for the quarter ending 2026-03-31 was 10.84%, a 22.34% increase year-over-year.
AMGEN INC roi for the quarter ending 2025-12-31 was 11.36%, a 93.16% increase year-over-year.
AMGEN INC roi for the quarter ending 2025-09-30 was 10.56%, a 78.36% increase year-over-year.
AMGEN INC roi for fiscal 2025 was 11.36%, a 93.16% increase from fiscal 2024.
AMGEN INC roi for fiscal 2024 was 5.88%, a 36.69% decline from fiscal 2023.
AMGEN INC roi for fiscal 2023 was 9.29%, a 37.32% decline from fiscal 2022.
AMGEN INC roi for fiscal 2022 was 14.82%, a 0.87% increase from fiscal 2021.